Literature DB >> 33881584

Comparison of N-methyl-2-pyrrolidone (NMP) and the "date rape" drug GHB: behavioral toxicology in the mouse model.

Raffaella Arfè1,2, Sabrine Bilel1, Micaela Tirri1, Paolo Frisoni1, Giovanni Serpelloni3, Margherita Neri1, Federica Boccuto1, Tatiana Bernardi4, Federica Foti2,5, Fabio De-Giorgio6,7, Matteo Marti8,9.   

Abstract

N-methyl-2-pyrrolidone (NMP) and γ-hydroxybutyrate acid (GHB) are synthetic solvents detected in the recreational drug market. GHB has sedative/hypnotic properties and is used for criminal purposes to compromise reaction ability and commit drug-facilitated sexual assaults and other crimes. NMP is a strong solubilizing solvent that has been used alone or mixed with GHB in case of abuse and robberies. The aim of this experimental study is to compare the acute pharmaco-toxicological effects of NMP and GHB on neurological signs (myoclonia, convulsions), sensorimotor (visual, acoustic, and overall tactile) responses, righting reflex, thermoregulation, and motor activity (bar, drag, and accelerod test) in CD-1 male mice. Moreover, since cardiorespiratory depression is one of the main adverse effects related to GHB intake, we investigated the effect of NMP and GHB on cardiorespiratory changes (heart rate, breath rate, oxygen saturation, and pulse distension) in mice. The present study demonstrates that NMP inhibited sensorimotor and motor responses and induced cardiorespiratory depression, with a lower potency and efficacy compared to GHB. These results suggest that NMP can hardly be used alone as a substance to perpetrate sexual assault or robberies.

Entities:  

Keywords:  Cardiorespiratory changes; Date-rape drug; Drug-facilitated crimes; Drug-facilitated sexual assault; GHB; Knock out drugs; NMP; New psychoactive substances; Sedative hypnotics

Year:  2021        PMID: 33881584     DOI: 10.1007/s00213-021-05852-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  48 in total

1.  In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45.

Authors:  S Bilel; N J Azevedo; R Arfè; M Tirri; A Gregori; G Serpelloni; F De-Giorgio; P Frisoni; M Neri; G Calò; M Marti
Journal:  Neuropharmacology       Date:  2020-04-25       Impact factor: 5.250

2.  2-pyrrolidinone--a cyclization product of gamma-aminobutyric acid detected in mouse brain.

Authors:  P S Callery; L A Geelhaar; M Stogniew
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

3.  Blood GHB concentrations and results of medical examinations in 25 car drivers in Norway.

Authors:  Muhammad S Al-Samarraie; Ritva Karinen; Jørg Mørland; Mimi Stokke Opdal
Journal:  Eur J Clin Pharmacol       Date:  2010-08-18       Impact factor: 2.953

4.  Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.

Authors:  Isabella Canazza; Andrea Ossato; Claudio Trapella; Anna Fantinati; Maria Antonietta De Luca; Giulia Margiani; Fabrizio Vincenzi; Claudia Rimondo; Fabiana Di Rosa; Adolfo Gregori; Katia Varani; Pier Andrea Borea; Giovanni Serpelloni; Matteo Marti
Journal:  Psychopharmacology (Berl)       Date:  2016-08-15       Impact factor: 4.530

5.  Gamma-aminobutyric acidB (GABAB)-receptor mediation of different in vivo effects of gamma-butyrolactone.

Authors:  Mauro A M Carai; Carla Lobina; Paola Maccioni; Claudia Cabras; Giancarlo Colombo; Gian Luigi Gessa
Journal:  J Pharmacol Sci       Date:  2008-02-09       Impact factor: 3.337

6.  Forensic cases involving the use of GHB in The Netherlands.

Authors:  Ingrid J Bosman; Klaas J Lusthof
Journal:  Forensic Sci Int       Date:  2003-04-23       Impact factor: 2.395

7.  Detection of the in vivo conversion of 2-pyrrolidinone to gamma-aminobutyric acid in mouse brain.

Authors:  P S Callery; M Stogniew; L A Geelhaar
Journal:  Biomed Mass Spectrom       Date:  1979-01

Review 8.  GHB receptor targets in the CNS: focus on high-affinity binding sites.

Authors:  Tina Bay; Laura F Eghorn; Anders B Klein; Petrine Wellendorph
Journal:  Biochem Pharmacol       Date:  2013-11-20       Impact factor: 5.858

9.  The acute oral toxicity and primary ocular and dermal irritation of selected N-alkyl-2-pyrrolidones.

Authors:  J M Ansell; J A Fowler
Journal:  Food Chem Toxicol       Date:  1988-05       Impact factor: 6.023

10.  Pharmacological and Behavioral Effects of the Synthetic Cannabinoid AKB48 in Rats.

Authors:  Sabrine Bilel; Micaela Tirri; Raffaella Arfè; Serena Stopponi; Laura Soverchia; Roberto Ciccocioppo; Paolo Frisoni; Sabina Strano-Rossi; Cristina Miliano; Fabio De-Giorgio; Giovanni Serpelloni; Anna Fantinati; Maria Antonietta De Luca; Margherita Neri; Matteo Marti
Journal:  Front Neurosci       Date:  2019-10-30       Impact factor: 4.677

View more
  2 in total

1.  In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice.

Authors:  Micaela Tirri; Raffaella Arfè; Sabrine Bilel; Giorgia Corli; Beatrice Marchetti; Anna Fantinati; Fabrizio Vincenzi; Fabio De-Giorgio; Cristian Camuto; Monica Mazzarino; Mario Barbieri; Rosa Maria Gaudio; Katia Varani; Pier Andrea Borea; Francesco Botrè; Matteo Marti
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

Review 2.  Epigenetic Studies for Evaluation of NPS Toxicity: Focus on Synthetic Cannabinoids and Cathinones.

Authors:  Leila Mazdai; Matteo Fabbri; Micaela Tirri; Giorgia Corli; Raffaella Arfè; Beatrice Marchetti; Sabrine Bilel; Eva Bergamin; Rosa Maria Gaudio; Michele Rubini; Fabio De-Giorgio; Matteo Marti
Journal:  Biomedicines       Date:  2022-06-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.